In summary, our study demonstrates that although ASCT2 activity is required for optimal tumor growth, thus rendering it a potentially good target for cancer therapy, the proposed functional coupling of ASCT2 and LAT1 is not obligatory across cancer types, a conclusion that extends the recent report of Broër et al. (36). This evidence concerns the gene SLC1A5 and neoplasm.